Medicinal Products With Known Potential To Prolong The Qt Interval has 1 known drug interaction based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Oxaliplatin. Patients taking Medicinal Products With Known Potential To Prolong The Qt Interval should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Major
- 1
Major (1)
- Medicinal Products With Known Potential To Prolong The Qt Interval + Oxaliplatin— QT interval prolongation and ventricular arrhythmias can occur with oxaliplatin. Avoid coadministration.